AGA
Altrinsic Global Advisors Portfolio holdings
AUM
$2.76B
This Quarter Return
+5.28%
1 Year Return
+17.53%
3 Year Return
+48.92%
5 Year Return
+91.21%
10 Year Return
+153.34%
AUM
$3.17B
AUM Growth
+$3.17B
(+7.6%)
Cap. Flow
+$124M
Cap. Flow
% of AUM
3.89%
Top 10 Holdings %
Top 10 Hldgs %
56.67%
Holding
93
New
10
Increased
30
Reduced
31
Closed
11
Top Buys
| 1 |
Alibaba
BABA
|
$71.3M |
| 2 |
Trip.com Group
TCOM
|
$46M |
| 3 |
American Financial Group
AFG
|
$27.9M |
| 4 |
Aon
AON
|
$16.7M |
| 5 |
FTI Consulting
FCN
|
$16.4M |
Top Sells
| 1 |
Baidu
BIDU
|
$95.5M |
| 2 |
HDFC Bank
HDB
|
$58M |
| 3 |
Camden Property Trust
CPT
|
$10.6M |
| 4 |
JWN
Nordstrom
JWN
|
$7.61M |
| 5 |
Tencent Music
TME
|
$4.99M |
Sector Composition
| 1 | Financials | 26.56% |
| 2 | Communication Services | 17.36% |
| 3 | Technology | 15.13% |
| 4 | Consumer Discretionary | 12.36% |
| 5 | Healthcare | 10.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cigna
CI
$80.3B
| $4.91M | 0.15% | 20,300 | – | – |
|
|
MORF
52
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $4.33M | 0.14% | 68,485 +20,000 | +41% | +$1.27M |
|
|
AERI
53
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.29M | 0.14% | 240,000 | – | – |
|
|
ICPT
54
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.9M | 0.12% | 168,800 -146,430 | -46% | -$3.38M |
|
55
KB Financial Group
KB
$28.6B
| $3.64M | 0.11% | 73,619 +9,313 | +14% | +$460K |
|
56
Xenon Pharmaceuticals
XENE
$2.98B
| $3.04M | 0.1% | 170,000 | – | – |
|
57
Lantheus
LNTH
$3.73B
| $2.78M | 0.09% | 130,000 -10,000 | -7% | -$214K |
|
58
Sangamo Therapeutics
SGMO
$157M
| $2.71M | 0.09% | 216,500 | – | – |
|
59
Brookdale Senior Living
BKD
$1.83B
| $2.68M | 0.08% | 442,452 +40,000 | +10% | +$242K |
|
60
Fate Therapeutics
FATE
$120M
| $2.47M | 0.08% | 30,000 -10,000 | -25% | -$825K |
|
61
Jazz Pharmaceuticals
JAZZ
$7.75B
| $2.47M | 0.08% | 15,000 | – | – |
|
62
Merit Medical Systems
MMSI
$5.36B
| $2.35M | 0.07% | 39,202 -10,000 | -20% | -$599K |
|
63
MacroGenics
MGNX
$112M
| $2.23M | 0.07% | 70,000 | – | – |
|
64
Axogen
AXGN
$743M
| $2.23M | 0.07% | 110,000 -10,000 | -8% | -$203K |
|
65
ProQR Therapeutics
PRQR
$237M
| $2.12M | 0.07% | 321,360 +80,000 | +33% | +$529K |
|
66
Envista
NVST
$3.52B
| $2.04M | 0.06% | 50,000 | – | – |
|
|
ITCI
67
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.04M | 0.06% | +60,000 | New | +$2.04M |
|
68
Kura Oncology
KURA
$686M
| $1.98M | 0.06% | 70,000 -5,000 | -7% | -$141K |
|
|
AGTC
69
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $1.91M | 0.06% | 376,900 +40,000 | +12% | +$203K |
|
70
Cabaletta Bio
CABA
$133M
| $1.33M | 0.04% | 120,000 +20,000 | +20% | +$222K |
|
71
JD.com
JD
$44.1B
| $1.3M | 0.04% | 15,399 -13,013 | -46% | -$1.1M |
|
72
Yum China
YUMC
$16.4B
| $1.25M | 0.04% | +21,387 | New | +$1.25M |
|
73
Infosys
INFY
$69.7B
| $1.22M | 0.04% | 65,229 +23,341 | +56% | +$437K |
|
74
Atara Biotherapeutics
ATRA
$84.6M
| $1.15M | 0.04% | 80,000 | – | – |
|
75
Tenaris
TS
$18.9B
| $1.01M | 0.03% | 44,442 -52,780 | -54% | -$1.2M |
|